Latest News

Date Title Topic
05 May 2017 ELCC 2017 Press Release: White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 May 2017 ELCC 2017 Press Release: Some Lung Cancer Patients Benefit from Immunotherapy Even After Disease Progression Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
04 May 2017 IMPAKT 2017: High Baseline TIL Levels Signal Superior Responses in HER2-Positive Breast Cancer Breast cancer
04 May 2017 IMPAKT 2017: Luminal Androgen Receptor (LAR) Subtype of Triple Negative Breast Cancer (TNBC) Demonstrates In Vitro and In Vivo Sensitivity to CDK4/6 Inhibition Breast cancer - Translational research - Basic science
04 May 2017 IMPAKT 2017: Few Variations in Somatic Mutations Observed Between Pregnant and Non-Pregnant Patients with Breast Cancer Breast cancer - Cancer in Special Situations - Translational research
04 May 2017 ELCC 2017 Press Release: Patients With Non-Small-Cell Lung Cancer Respond Best to Salvage Chemotherapy When Pre-Treated With PD-1/PD-L1 Inhibitors Lung and other thoracic tumours
Webcasts
Webcasts
03 May 2017 FDA Grants Accelerated Approval to Durvalumab for Locally Advanced or Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
03 May 2017 FDA Approves Midostaurin and a Companion Diagnostic Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
Prostate Cancer
02 May 2017 FDA Grants Accelerated Approval to Brigatinib and Breakthrough Therapy Designation to Lorlatinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 May 2017 ELCC 2017 Press Release: Men Need More Frequent Lung Cancer Screening Than Women Diagnosis, Imaging and Staging - Lung and other thoracic tumours
28 Apr 2017 FDA Expands Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Apr 2017 Annals of Oncology Press Release: England’s Cancer Drugs Fund ‘Failed to Deliver Meaningful Value to Patients and Society’ Bioethics, legal and economic issues